Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perampanel add-on therapy in epilepsy
ChiCTR2100051885Phase 4Recruiting
- Sponsor
- Huashan Hospital
- Start
- Jun 2021
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of perampanel in epilepsy, sponsored by Huashan Hospital. Primary endpoints: Perampanel plasma concentration, Other antiepileptic drugs concentration and 5 more. Started Jun 2021; status: recruiting.
02
Drugs
perampanel
03
Conditions
epilepsy
Beyond the preview
Go deeper on ChiCTR2100051885.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100051885.